X Ray News and Research

RSS

New foundational research may advance pharmacological therapies for neurological disorders

Investigators in the Hotchkiss Brain Institute, Faculty of Medicine, have made a major breakthrough in our understanding of nerve impulse generation within the brain.

17 Feb 2010

Bedford Laboratories launches Indomethacin for Injection

Bedford Laboratories™, a division of Ben Venue Laboratories, Inc., a provider of select specialty injectables, is pleased to announce the addition of Indomethacin for Injection to its existing product line. This product is AP rated and is equivalent to Indocin® by Lundbeck, Inc. Indomethacin for Injection is indicated to close a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750 g when after 48 hours usual medical management (e.g., fluid restriction, diuretics, digitalis, respiratory support, etc.) is ineffective.

17 Feb 2010

NorTech announces winners of annual Innovation Awards program

NorTech, in partnership with Crain's Cleveland Business, is pleased to announce the winners of its annual Innovation Awards program which honors the achievements of Northeast Ohio's most innovative organizations and leaders.

16 Feb 2010

APS-AAPT joint meeting: Highlights

Secret military projects, powerful collisions at the LHC, future international physics projects, and lots of new data from around the universe will be featured in talks at this year's spring meeting of The American Physical Society (APS), the largest professional society of physicists in the world. This year, APS is joining with the American Association of Physics Teachers (AAPT), the world's largest society of physics teachers, for a joint meeting from February 13-17, 2010 at the Marriott Wardman Park Hotel in Washington, D.C.

15 Feb 2010

Researchers describe the structure of ToxT that controls virulent nature of Vibrio cholerae

In a new study, Dartmouth researchers describe the structure of a protein called ToxT that controls the virulent nature of Vibrio cholerae, the bacteria that causes cholera. Buried within ToxT, the researchers were surprised to find a fatty acid that appears to inhibit ToxT, which prevents the bacteria from causing cholera.

14 Feb 2010

Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.

12 Feb 2010

New amplitude gating technique helps scanners pinpoint tumors

When one diagnoses a cancer patient, it's important to gather as much information about that person as possible. But who would have thought an accurate diagnosis would depend on throwing some of that information away?

12 Feb 2010

Boston Scientific combines Cardiovascular Group and Cardiac Rhythm Management Group

Boston Scientific Corporation today announced a series of management changes and restructuring initiatives designed to strengthen the Company and position it for long-term success.

11 Feb 2010

Toshiba America Medical Systems' cardiovascular X-ray service receives top ranking

As health care facilities today seek the best value in imaging and customer service, Toshiba America Medical Systems, Inc.’s Service organization strives to deliver top-tier service and customer satisfaction. The result of this dedication was once again confirmed by IMV, Ltd., which provides independent analysis of service trends in the imaging industry. In IMV’s 2009 ServiceTrak™ Imaging report on cardiovascular X-ray system service, Toshiba received more top rankings than any other imaging vendor.

11 Feb 2010

Boston Scientific rebuts HeartRhythm's cardiac resynchronization therapy defibrillator implantation article

Boston Scientific Corporation today rebutted an article published in the journal HeartRhythm. The article reported a case summary of a patient who had been implanted subcutaneously with a Cognis cardiac resynchronization therapy defibrillator. The article suggested a weakened header bond was responsible for the abnormal sensing and pacing impedance experienced by the patient.

11 Feb 2010

Boston Scientific reports fourth quarter and full year 2009 results

Boston Scientific Corporation today announced financial results for the fourth quarter and full year ended December 31, 2009, as well as guidance for net sales and earnings per share (EPS) for the first quarter and full year 2010.

10 Feb 2010

Bulgaria deploys Gemalto' smart cards to secure access to personal health records for military personnel

Gemalto, the world leader in digital security, today announced that Bulgaria has started deploying its smart cards to secure access to personal health records for the country’s military personnel and their family.

10 Feb 2010

Hospitals use new robotic catheter guidance system to treat abnormal heart rhythms

The robotic system "enhances a doctor's natural ability, and we believe it will contribute to improved procedural outcomes," said Dr. David Wilber of Loyola University Health System, a nationally known researcher in heart rhythm disorders.

10 Feb 2010

FDA announces initiative to reduce cancer risk from medical imaging procedures

The U.S. Food and Drug Administration today announced an initiative to reduce unnecessary radiation exposure from three types of medical imaging procedures: computed tomography (CT), nuclear medicine studies, and fluoroscopy.

10 Feb 2010

OlFactor Laboratories acquires exclusive license to patented technology from UC Riverside

OlFactor Laboratories, Inc., a majority owned subsidiary of Avisio, Inc. acquired an exclusive license to patented technology from UC Riverside.

10 Feb 2010

Stereotaxis Magnetic Navigation System installed at CHMC, Taiwan

Stereotaxis today announced the installation of its first Stereotaxis Magnetic Navigation System in Taiwan at Cheng-Hsin General Hospital (CHMC) located in Taipei. CHMC hosted a Grand Opening event on January 26 that received wide coverage throughout the area and, to date, ten procedures have been successfully performed using Stereotaxis at the hospital.

8 Feb 2010

MetroSouth Medical Center launches campaign to raise awareness on heart disease

More than 100 MetroSouth Medical Center staffers tossed off their sterile booties, donned cowboy boots and line danced to the tune "Achy, Breaky Heart," made famous by Billy Ray Cyrus.

6 Feb 2010

AMAG Pharmaceuticals releases safety update on Feraheme Injection

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today provided a safety update on Feraheme® (ferumoxytol) Injection for intravenous use.

6 Feb 2010

Local organizations team up to support Haiti's healthcare system

Injured Haitians desperately in need of medical treatment will soon have advanced technology available to the medical professionals providing their care. Through a partnership of Stamford Hospital, FUJIFILM Medical Systems USA (Fujifilm), and AmeriCares, a portable digital x-ray system is being donated to the Haitian relief effort and will be sent to a hospital where currently x-ray capabilities are simply non-existent.

6 Feb 2010

Amantadine binds to and blocks critical M2 proton channel necessary for influenza virus to infect healthy cells

Antiviral drugs block influenza A viruses from reproducing and spreading by attaching to a site within a proton channel necessary for the virus to infect healthy cells, according to a research project led by Iowa State University's Mei Hong and published in the Feb. 4 issue of the journal Nature.

4 Feb 2010

X Ray News and Research

New foundational research may advance pharmacological therapies for neurological disorders

Bedford Laboratories launches Indomethacin for Injection

NorTech announces winners of annual Innovation Awards program

APS-AAPT joint meeting: Highlights

Researchers describe the structure of ToxT that controls virulent nature of Vibrio cholerae

Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease

New amplitude gating technique helps scanners pinpoint tumors

Boston Scientific combines Cardiovascular Group and Cardiac Rhythm Management Group

Toshiba America Medical Systems' cardiovascular X-ray service receives top ranking

Boston Scientific rebuts HeartRhythm's cardiac resynchronization therapy defibrillator implantation article

Boston Scientific reports fourth quarter and full year 2009 results

Bulgaria deploys Gemalto' smart cards to secure access to personal health records for military personnel

Hospitals use new robotic catheter guidance system to treat abnormal heart rhythms

FDA announces initiative to reduce cancer risk from medical imaging procedures

OlFactor Laboratories acquires exclusive license to patented technology from UC Riverside

Stereotaxis Magnetic Navigation System installed at CHMC, Taiwan

MetroSouth Medical Center launches campaign to raise awareness on heart disease

AMAG Pharmaceuticals releases safety update on Feraheme Injection

Local organizations team up to support Haiti's healthcare system

Amantadine binds to and blocks critical M2 proton channel necessary for influenza virus to infect healthy cells

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News